Research Laboratory, Carlos Haya Hospital, Málaga, Spain.
Allergy Asthma Immunol Res. 2012 Sep;4(5):251-63. doi: 10.4168/aair.2012.4.5.251. Epub 2012 May 30.
Hypersensitivity drug reactions (HDR) consist of an individual abnormal response with the involvement of the immunological system. In addition to specific immunological mechanisms where specific antibodies or sensitised T cells participate, release of inflammatory mediators by non-specific immunological recognition may also occur. Within this category are one of the most common groups of drugs, the non-steroidal anti-inflammatory drugs. In addition to chemical drugs new emerging ones with an increasing protagonism are biological agents like humanised antibodies and others. For IgE dependent reactions both in vivo and in vitro tests can be used for the immunological evaluation. Sensitivity of these is not optimal and very often a drug provocation test must be considered for knowing the mechanism involved and/or establishing the diagnosis. For non-immediate reactions also both in vivo and in vitro tests can be used. Sensitivity for in vivo tests is generally low and in vitro tests may be needed for the immunological evaluation. Immunohistochemical studies of the affected tissue enable a more precise classification of non-immediate reactions. The monitorization of the acute response of the reactions has given clues for understanding these reactions and has promising results for the future of the immunological evaluation of HDR.
药物超敏反应(HDR)由涉及免疫系统的个体异常反应组成。除了特定的免疫机制,其中涉及特定的抗体或致敏 T 细胞,非特异性免疫识别也可能导致炎症介质的释放。在这一类别中,有一类是最常见的药物群体,即非甾体抗炎药。除了化学药物,新出现的具有越来越重要作用的还有生物制剂,如人源化抗体等。对于 IgE 依赖性反应,无论是体内还是体外试验都可用于免疫评估。这些试验的敏感性并不理想,因此常常需要进行药物激发试验,以了解所涉及的机制和/或建立诊断。对于非即刻反应,也可同时使用体内和体外试验。体内试验的敏感性通常较低,因此可能需要进行体外试验进行免疫评估。对受影响组织的免疫组织化学研究能够更精确地分类非即刻反应。对反应的急性反应的监测为理解这些反应提供了线索,并为 HDR 的免疫评估的未来带来了有希望的结果。